Oral pentasa in the treatment of active Crohn’s disease: A meta-analysis of double-blind, placebo-controlled trials
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 2 (5) , 379-388
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapeutics and inflammatory bowel disease: A guide to the interpretation of randomized controlled trialsGastroenterology, 1996
- Second trial of mesalamine therapy in the treatment of active Crohn's diseaseGastroenterology, 1994
- Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trialGastroenterology, 1993
- A general parametric approach to the meta‐analysis of randomized clinical trialsStatistics in Medicine, 1991
- Effect of Cigarette Smoking on Recurrence of Crohn's DiseaseGastroenterology, 1990
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Long-term follow-up of patients with Crohn's diseaseGastroenterology, 1985
- European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatmentGastroenterology, 1984
- National Cooperative Crohn's Disease Study: Results of drug treatmentGastroenterology, 1979
- Radiographic findings of the National Cooperative Crohn's Disease StudyGastroenterology, 1979